Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 67 for “"Aztreonam"”.

  1. Avaliação do sinergismo entre ceftazidima/avibactam-aztreonam e aztreonam/avibactam frente a Klebsiella pneumoniae utilizando espectrometria de massa maldi-tof

    … combinações ceftazidima/avibactam associada ao aztreonam e aztreonam/avibactam frente a isolados clínicos produtores de NDM, utilizando a espectrometria de massas MALDI-TOF como ferramenta fenotípica rápida para análise do crescimento bacteriano. Foram incluídos no estudo 17 isolados clínicos de …

    brazil-ufrgs Repository record for Avaliação do sinergismo entre ceftazidima/avibactam-aztreonam e aztreonam/avibactam frente a Klebsiella pneumoniae utilizando espectrometria de massa maldi-tof (opens in a new tab)

  2. Characterizing Aztreonam Resistance in Pseudomonas aeruginosa through Artificial Selection and Whole Genome Sequencing

    … chromosomally-encoded mutations causing aztreonam resistance in Pseudomonas aeruginosa and characterized the secondary consequences of resistance development. We identified 19 recurrently mutated genes associated with aztreonam resistance. The most frequently observed mutations affected …

    washington Repository record for Characterizing Aztreonam Resistance in Pseudomonas aeruginosa through Artificial Selection and Whole Genome Sequencing (opens in a new tab)

  3. Contributions and Evolutionary Potential of ampC Mutations to confer Aztreonam Resistance in Pseudomonas aeruginosa

    Aztreonam is a synthetic monobactam antibiotic that is increasingly used for chronic suppressive therapy in Cystic Fibrosis (CF) patients with Pseudomonas aeruginosa airway infection. P. aeruginosa can accumulate mutations in the chromosomal ampC β-lactamase which promote aztreonam resistance, but …

    washington Repository record for Contributions and Evolutionary Potential of ampC Mutations to confer Aztreonam Resistance in Pseudomonas aeruginosa (opens in a new tab)

  4. Μελέτη της αποτελεσματικότητας των καρβαπενεμών εναντίον κλινικού στελέχους που παράγει μέταλλο-β-λακταμάση σε πειραματικό μοντέλο ενδοπεριτοναϊκού αποστήματος

    … efficacy of imipenem, meropenem, ertapenem and aztreonam against a carbapenem-susceptible MBL-producing clinical Escherichia coli strain in a rabbit intra-abdominal abscess model.Methods: Rabbits were inoculated intraperitoneally with 108 cfu/ml of VIM-1-positive E. coli and were assigned to …

    greece Repository record for Μελέτη της αποτελεσματικότητας των καρβαπενεμών εναντίον κλινικού στελέχους που παράγει μέταλλο-β-λακταμάση σε πειραματικό μοντέλο ενδοπεριτοναϊκού αποστήματος (opens in a new tab)

  5. Systems Pharmacology Approaches to Describe and Exploit the Pathways to Polymyxin and β-lactam Resistance in Metallo-β-lactamase-producing Gram Negatives

    … all clinically used β-lactams, with exception of aztreonam. Unfortunately, bacteria that harbor MBLs will often co-express other enzymes, such as extended spectrum β-lactamases (ESBLs), that do degrade aztreonam. This co-expression of MBLs and ESBLs produces strains that are functionally resistant …

    buffalo Repository record for Systems Pharmacology Approaches to Describe and Exploit the Pathways to Polymyxin and β-lactam Resistance in Metallo-β-lactamase-producing Gram Negatives (opens in a new tab)

  6. Φαρμακοκινητική στο οφθαλμό των νεώτερων β-λακταμών υπό την επήρεια της ακεταζολαμίδης

    … the penetration of cefotaxime, ceftraixone and aztreonam into the non inflammed human aqueous humor was comparatively studied. One hundred and forty two patients (mean age 73.2 years) submitted to cataract extraction were divided into subgroups a and b, subgroup b receiving the antibiotic plus …

    greece Repository record for Φαρμακοκινητική στο οφθαλμό των νεώτερων β-λακταμών υπό την επήρεια της ακεταζολαμίδης (opens in a new tab)

  7. Avaliação de metodologias alternativas para a detecção rápida e acurada de resistência às opções terapêuticas no tratamento de bacilos gram-negativos resistentes aos carbapenêmicos

    … hospitalares e maior mortalidade. A combinação aztreonam/ceftazidima-avibactam e as polimixinas são opções terapêuticas essenciais para o tratamento de infecções por BGN-RC, especialmente em casos de isolados produtores de metalo-beta-lactamases, associadas ou não a serina-carbapenemases. A …

    brazil-ufrgs Repository record for Avaliação de metodologias alternativas para a detecção rápida e acurada de resistência às opções terapêuticas no tratamento de bacilos gram-negativos resistentes aos carbapenêmicos (opens in a new tab)

  8. Development of polymyxin and aminoglycoside-based outer membrane permeabilizing antibiotic potentiators

    … rifampicin, erythromycin, ceftazidime and aztreonam against multidrug-resistant Gram-negative bacteria; (2) guanidinylated amphiphilic tobramycin derivatives which enhanced ceftazidime and aztreonam, and their combinations with avibactam against β-lactamase harboring Pseudomonas aeruginosa; …

    manitoba Repository record for Development of polymyxin and aminoglycoside-based outer membrane permeabilizing antibiotic potentiators (opens in a new tab)

  9. Διείσδυση νεώτερων β-λακταμικών αντιβιοτικών στην κεφαλή του ανθρώπινου μηριαίου οστού

    … rabbits, dogs, etc. animals. (5) The antibiotics Aztreonam, Ceftazidime, and Cefamandole, create good bone levels. (6) In the question “Can these antibiotics kill Microbia”? the answer is: (a)Aztreonam is good for Pseudomonas Aeruginosa. Ceftazidime is also good for Pseudomonas Aeruginosa. (c) …

    greece Repository record for Διείσδυση νεώτερων β-λακταμικών αντιβιοτικών στην κεφαλή του ανθρώπινου μηριαίου οστού (opens in a new tab)

  10. Exploring the Effects of Inhaled Antibiotics on the Cystic Fibrosis Lung Microbiome and Pseudomonas aeruginosa Population Diversity and their Clinical Implications

    … we sought to investigate how inhaled aztreonam and tobramycin affect the CF lung microbiome and whether the microbiome can be used as a tool to predict patient response. We showed that the lung microbiome is relatively fixed in adults with CF despite potent inhaled antibacterial …

    calgary Repository record for Exploring the Effects of Inhaled Antibiotics on the Cystic Fibrosis Lung Microbiome and Pseudomonas aeruginosa Population Diversity and their Clinical Implications (opens in a new tab)

  11. Development of meaningful clinical trial endpoints in bronchiectasis

    … of the AIR-BX1 and 2 studies comparing inhaled aztreonam versus placebo in bronchiectasis with the primary endpoint of change in the quality of life bronchiectasis (QOL-B) respiratory symptom score was conducted. Individual items from QOL-B were extracted as representing severity of nine …

    dundee Repository record for Development of meaningful clinical trial endpoints in bronchiectasis (opens in a new tab) Download PDF for Development of meaningful clinical trial endpoints in bronchiectasis (opens in a new tab)

  12. Μοριακός χαρακτηρισμός του πληθυσμού Pseudomonas aeruginosa που απομονώθηκε από υδάτινα περιβάλλοντα του ελλαδικού χώρου

    … relevant antibiotics such as cefotaxime, aztreonam, ceftazidime, cefepime and meropenem, were screened phenotypically and by molecular methods for the presence of extended spectrum β-lactamases (ESBLs), while 77 isolates with various resistant phenotypes were screened for the presence of …

    greece Repository record for Μοριακός χαρακτηρισμός του πληθυσμού Pseudomonas aeruginosa που απομονώθηκε από υδάτινα περιβάλλοντα του ελλαδικού χώρου (opens in a new tab)

  13. Χαρακτηρισμός κλινικών στελεχών Gram-αρνητικών βακτηρίων με αντοχή στα β-λακταμικά αντιβιοτικά

    … to cefoxitin and ceftibuten as well as to aztreonam, cefotaxime, and ceftazidime. Resistance could be transferred by conjugation or transformation with plasmid DNA into Eschenichia coli and was due to the production of a β-lactamase with an isoelectric point of 8.4 named MIR-1. In E. coli, …

    greece Repository record for Χαρακτηρισμός κλινικών στελεχών Gram-αρνητικών βακτηρίων με αντοχή στα β-λακταμικά αντιβιοτικά (opens in a new tab)

  14. Qualidade de carcaças de frango de abatedouros do Estado de Minas Gerais: ocorrência de Campylobacter jejuni e perfil de resistência a antimicrobianos

    … as cepas foram resistentes aos antimicrobianos Aztreonam, Cefalotina, Cefoxitina, Sulfa+trimetoprim e Vancomicina, e 95 % das cepas testadas foram resistentes ao Ácido Nalidíxico, Cefotaxima, Cefuroxima e à Ciprofloxacina. Todas as cepas avaliadas apresentaram sensibilidade à Polimixina B. …

    brazil-ufv Repository record for Qualidade de carcaças de frango de abatedouros do Estado de Minas Gerais: ocorrência de Campylobacter jejuni e perfil de resistência a antimicrobianos (opens in a new tab)

  15. Novel β-Lactams, their Antibacterial and Pharmacokinetic Properties and Pre-Clinical Evaluation

    … of organisms with the exception of cefixime and aztreonam which had reduced or little activity against gram positive organisms. The β-lactamase inhibitor was slightly less active than clavulanic acid, however, was more stable to environmental conditions such as heat and moisture. All of the …

    aston Repository record for Novel β-Lactams, their Antibacterial and Pharmacokinetic Properties and Pre-Clinical Evaluation (opens in a new tab) Download PDF for Novel β-Lactams, their Antibacterial and Pharmacokinetic Properties and Pre-Clinical Evaluation (opens in a new tab)

  16. Βιοχημική, μοριακή και γενετική διερεύνηση της αντίδρασης κλινικών στελεχών Klebsiella pneumoniae στα β-λακταμικά αντιβιοτικά

    … resistance to 3rd generation cephalosporins and aztreonam. Those strains expressed a SHV-5 type β-lactamase. In group B cefoxitin and penicillin / inhibitor combination resistant strains were included. The latter phenotype is due to the acquisition of small plasmid coding for LAT-2 β-lactamase. A …

    greece Repository record for Βιοχημική, μοριακή και γενετική διερεύνηση της αντίδρασης κλινικών στελεχών Klebsiella pneumoniae στα β-λακταμικά αντιβιοτικά (opens in a new tab)

  17. The efficacy of last-line and experimental antimicrobials against Stenotrophomonas maltophilia and the characterisation of resistant mutant

    … with ceftazidime) new combinations strategies (aztreonam/avibactam or aztreonam/bicyclic boronate 2) or new inhibitors (MBL inhibitors in combination with meropenem) showed significant promise. In addition, the sideromimic modification of γ lactam antibiotic, lactivicin (LTV-17) was found tp …

    bristol Repository record for The efficacy of last-line and experimental antimicrobials against Stenotrophomonas maltophilia and the characterisation of resistant mutant (opens in a new tab) Download PDF for The efficacy of last-line and experimental antimicrobials against Stenotrophomonas maltophilia and the characterisation of resistant mutant (opens in a new tab)

  18. Examining the Distribution of the Extracellular Polymeric Substances in the Biofilms of the Liverpool Epidemic Strain of Pseudomonas aeruginosa

    … standard P. aeruginosa PAO1. When treated with aztreonam, LESlike4 exhibited an increase in EPS components that was not seen in LES400 or in PAO1. While these specific isolates share many of the same genes, each has a unique profile of SNPs and genetic elements that are likely responsible for …

    guelph Repository record for Examining the Distribution of the Extracellular Polymeric Substances in the Biofilms of the Liverpool Epidemic Strain of Pseudomonas aeruginosa (opens in a new tab)

  19. The Diversity Found Among Carbapenem-Resistant Bacteria

    … imparts a greater fitness when grown in aztreonam (a monobactam) than ceftazidime (a cephalosporin). Finally, we show that individually, these β-lactamases do not account for the elevated levels of resistance seen in the parent strain, indicating that the passive resistance mechanisms …

    byu Repository record for The Diversity Found Among Carbapenem-Resistant Bacteria (opens in a new tab) Download PDF for The Diversity Found Among Carbapenem-Resistant Bacteria (opens in a new tab)

Page 1 of 4